Blood healthy therapy is to reduce the incidence of acute coronary syndrome and stroke

What is it about?

Cardiovascular atherosclerotic disease is the leading cause of death in China and in Western nations. The factors in blood play an important role as a bridge between plaque rupture and subsequent clinical events. Blood healthy therapy, as a therapeutic apheresis to decrease the blood hypercoagulability to modulate the blood to be thrombosis resisting, would be considered as a potential therapeutic approach to reduce the incidence of acute coronary syndrome and stroke.

Featured Image

Why is it important?

The assumption that identifying lesions prone to rupture will prevent acute coronary events was unrealistic, and little management to efficiently decline the frequency of plaque rupture or erosion, blood healthy therapy, as a therapeutic apheresis to decrease the blood hypercoagulability to modulate the blood to be thrombosis resisting, is the first time to be considered as a potential therapeutic approach to reduce the incidence of acute coronary syndrome and stroke.

Perspectives